NEJM Evidence Issues Research Articles in January 2024 Edition
March 28, 2024
March 28, 2024
WALTHAM, Massachusetts, March 28 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its January 2024 edition (Vol. 3, No. 1):
Original Articles:
* Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer
* Apixaban versus Aspirin for Embolic Stroke of Undetermined Source
* High- . . .
Original Articles:
* Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer
* Apixaban versus Aspirin for Embolic Stroke of Undetermined Source
* High- . . .